| Financial Year |
March 31 2023 |
| Monetary Funds |
4,524,450,908.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
936,988,627.35 |
| Accounts Receivable |
6,311,809,426.31 |
| Advances to Suppliers |
496,103,610.52 |
| Other Receivables |
184,757,156.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,657,585,240.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
364,522,750.85 |
| Total Current Assets |
15,650,253,357.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
112,672,854.02 |
| Investment Properties |
-- |
| Fixed Assetes |
5,150,389,027.77 |
| Under-construction Projects |
586,245,859.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
858,355,955.74 |
| R&D expenses |
-- |
| Goodwill |
117,684,578.04 |
| Long-Term Deferred and Prepaid Expenses |
31,651,290.85 |
| Deferred Income Tax Assets |
313,208,027.73 |
| Other Non-Current Assets |
38,657,320.40 |
| Sub-Total of Non-Current Assets |
7,241,773,111.65 |
| Total Assets |
22,892,026,469.62 |
| Short-Term Loans |
10,895,953,523.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
452,006,237.25 |
| Accounts Payable |
1,006,788,268.50 |
| Accounts Received In Advance |
6,853,486.54 |
| Employee Compensation Payable |
16,760,156.78 |
| Taxes Payable |
43,048,302.10 |
| Interest Payable |
-- |
| Dividend Payable |
455,481.08 |
| Other payables |
968,879,814.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,305,037,684.60 |
| Other Current Liabilities |
325,538,130.90 |
| Sub-Total of Current Liabilities |
15,522,431,560.58 |
| Long-term Loans |
2,045,560,267.40 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
225,893,556.61 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
28,274,150.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,377,405,555.11 |
| Total Liabilities |
17,899,837,115.69 |
| Paid-In Capital(Or Share Stock) |
1,371,366,248.00 |
| Capital Surplus |
1,514,389,571.46 |
| Surplus Reserve |
161,642,698.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
637,628,323.44 |
| Minority Stockholder's Interest |
1,221,183,841.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,771,005,512.36 |
| Owner's Equity（Stockholder's Equity） |
4,992,189,353.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,892,026,469.62 |
